Final Programme

Instructions for Speakers

28/04/2007
10.00 - 20.00   Registration
     
15.30 - 17.00   WorldWIDE Satellite Symposium
Orange Hall
 Natural approaches to improving blood glucose control: a hormonal focus on Type 2 diabetes
     
17.15 - 17.30   Opening Ceremony
Plenary Hall
     
17.30 - 18.15   EJE Prize Lecture
Plenary Hall
 Chairs: P. Beck-Peccoz (Italy) & I. Gerendai (Hungary)
EJE1 Cortisol and cardiovascular disease
B. R. Walker (United Kingdom)
     
18.15 - 19.00   Geoffrey Harris Prize Lecture
Plenary Hall
 Chairs: S. W. J. Lamberts (The Netherlands) & L. Martini (Italy)
GH1 Neuroendocrine control of steroid biosynthesis within the hypothalamus
H. Vaudry (France)
     
19.00 - 21.00   Welcome Reception - A taste of Hungary (wine and cheese party with music on-site)
     

29/04/2007
08.00 - 08.45   Plenary Lecture 1
Plenary Hall
 Chairs: P. Bouchard (France) & I. Huhtaniemi (Finland)
PL1 Reading beyond the sequence- the plasticity of the LH/CG-LH receptor system
J. Gromoll (Germany)
     
08.45 - 10.25   Symposium 1 - Clinical: Hypopituitarism
Orange Hall
 Chairs: J. Jorgensen (Denmark) & V. Popovic (Serbia)
08:45 S1.1 Traumatic brain injury-induced hypopituitarism: whom and when to test?
C. J. Thompson (Ireland)
09:10 S1.2 Morbidity and mortality
B. A. Bengtsson (Sweden)
09:35 S1.3 Hypocorticotropism
S. Tsagarakis (Greece)
10:00 S1.4 Familial neurogenic diabetes insipidus
S. Rittig (Denmark)
     
08.45 - 10.25   Symposium 2 - Basic to Clinical: Hormones and the brain
Yellow Hall
 Chairs: J. Isgaard (Sweden) & M. Motta (Italy)
08:45 S2.1 Thyroid hormone regulation of neural and oligodendrocyte precursors in the mature brain: a possibility for remyelination and neuroprotection
L. Calza (Italy)
09:10 S2.2 Neuroprotective actions of estrogens in the central nervous system
L. M. Garcia-Segura (Spain)
09:35 S2.3 Estrogen receptor signalling and cerebrovascular disease
T. Olsson (Sweden)
10:00 S2.4 Immunesenescence and Steroid Hormones
W. Arlt (United Kingdom)
     
08.45 - 10.25   Symposium 3 - Basic: Signaling and regulation of G-Protein-coupled hormone receptors
Green Hall
 Chairs: T. Gudermann (Germany) & A. Spat (Hungary)
08:45 S3.1 Trafficking and signaling of angiotensin receptors
L. Hunyady (Hungary)
09:10 S3.2 Pharmacological chaperones rescue the membrane expression and function of the V1a/V3 receptor
E. Clauser (France)
09:35 S3.3 Functional impact of GPCR heterodimerization
H. Biebermann (Germany)
10:00 S3.4 Ago-allosteric effects of agonist drugs on 7TM receptors and their endogenous hormones - example from the ghrelin receptor
T. W. Schwartz (Denmark)
     
10.25  -  10.55   Coffee Break and Exhibition
     
10.55 - 12.35   Symposium 4 - Clinical: Gastroentereopancreatic endocrine tumors (GEP ET)
Plenary Hall
 Chairs: Zs. Tulassay (Hungary) & A. van der Lely (The Netherlands)
10:55 S4.1 Pathological classification of GEP neuroendocrine tumors
M. Papotti (Italy)
11:20 S4.2 Biological, morphological work-up and screening for inherited disease
B. Skogseid (Sweden)
11:45 S4.3 Prognosis of GEP ET
E. Baudin (France)
12:10 S4.4 Therapeutic management of GEP ET
P. Ruszniewski (France)
     
10.55 - 12.35   Symposium 5 - Basic: Novel bioactive peptides: Lessons from animal
Yellow Hall
 Chairs: L. De Lecea (USA) & A. Grossman (United Kingdom)
10:55 S5.1 Discovery of novel bioactive peptides: the uniquely important contribution of amphibians to mammalian neuropeptidology
H. Vaudry (France)
11:20 S5.2 Comparative approaches to resolve the complexities of human appetite regulation
D. Larhammar (Sweden)
11:45 S5.3 Bioactive peptides in invertebrate model organisms
L. Schoofs (Belgium)
12:10 S5.4 Somatostatin, cortistatin and their new and old receptors: from comparative to translational endocrinology
J. P. Castaño (Spain)
     
10.55 - 12.35   Oral Communication 1: Thyroid Clinical
Green Hall
 Chairs: M. Erdogan (Turkey) & B. Hallehgren (Sweden)
OC1.1 Prevalence of inactivating TSH receptor (TSHR) mutations in a large series of pediatric subjects with non-autoimmune mild hyper-thyrotropinemia (hyperTSH).
Cordella Daniela, De Marco Alessandro, Calebiro Davide, de Filippis Tiziana, Radetti Giorgio, Weber Giovanna, Vigone Maria Cristina, Cappa Marco, Sartorio Alessandro, Busnelli Marta, Bonomi Marco, Chini Bice, Beck-Peccoz Paolo, Persani Luca
Dept of Medical Sciences, University of Milan and Ist. Auxologico Italiano, Milan, Italy Lab of Experimental Endocrinology, IRCCS Ist Auxologico Italiano, Milan, Italy Pediatric Unit, Bolzano, Italy Pediatric Unit, Bambin Gesù Hosp, Rome, Italy
OC1.2 Expression gene profile may be useful for the diagnosis of thyroid malignancies
Piampiani Pamela, Romei Cristina, Cosci Barbara, Vivaldi Agnese, Ciampi Raffaele, Viola David, Bottici Valeria, Giannini Riccardo, Basolo Fulvio, Pinchera Aldo, Elisei Rossella
Department of Endocrinology, University of Pisa, Pisa, Italy Department of Oncology, University of Pisa, Pisa, Italy
OC1.3 Persistence of Decreased Peripheral B Lymphocytes after Rituximab Treatment is Associated to Inactive Disease in Patients with Thyroid-Associated Ophthalmopathy
Campi Irene, Vannucchi Guia, Covelli Danila, Bonara Paola, Currò Nicola, Dazzi Davide, Pirola Giacinta, Rossi Stefania, Guastella Claudio, Beck-Peccoz Paolo, Salvi Mario
Endocrine Unit Department of Medical Science, Fondazione Policlinico IRCCS, University of Milan, Milan, Italy Internal Medicine, Fondazione Policlinico IRCCS, University of Milan, Milan, Italy Ophthalmology, Fondazione Policlinico IRCC, University of Milan, Milan, Italy Internal Medicine, Ospedale di Fidenza, Fidenza, Italy
OC1.4 A novel tyrosine-kinases selective inhibitor with anti-tumoral efficacy (Sunitinib) induces a block in iodine uptake and transient hypothyroidism
Mannavola Deborah, Vannucchi Guia, Carletto Marco, Longari Virgilio, Bertuelli Rossella, Coco Paola, Casali Paolo, Beck-Peccoz Paolo, Fugazzola Laura
Endocrine Unit, Dept. of Medical Sciences, University of Milan, Fondazione Policlinico IRCCS , Milan, Italy Nuclear Medicine Unit, Fondazione Policlinico IRCCS, Milan, Italy Dept. of Oncology, Istituto Nazionale dei Tumori, Milan, Italy
OC1.5 CTLA- 4 Gene Polymorphisms and Autoimmune Thyroid Diseases: Meta-analyses of Published and Individual-level Data
Kavvoura Fotini, Akamizu Takashi, Awata Takuya, Ban Yoshiyuki, Chistiakov Dimitry, Frydecka Irena, Ghaderi Abbas, Gough Stephen, Hiromatsu Yuji, Ploski Rafal, Wang Pei-Wen, Ban Yoshio, Bednarczuk Tomasz, Chistiakova Emma, Chojm Marcin, Heward Joanne, Hiratani Hitomi, Juo Suh-Hang Hank, Karabon Lidia, Katayama Shigehiro, Kurihara Susumu, Liu Rue-Tsuan, Miyake Ikuyo, Omrani Gholam-Hossein, Pawlak Edyta, Taniyama Matsuo, Tozaki Teruaki, Ioannidis John P.A.
Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece Translational Research Center, Kyoto University Hospital, Kyoto University School of Medicine, Kyoto, Japan Division of Endocrinology and Diabetes, Department of Medicine, Saitama Medical University, Saitama, Japan Third Department of Internal Medicine Showa University School of Medicine, Tokyo, Japan
OC1.6 Sensitization against Soybean may induce an increase in the levels of anti-thyroid peroxidase antibodies in thyroid autoimmunity
Molnár Ildikó
Kenézy County and Teaching Hospital , Debrecen, Hungary
OC1.7 Pregnant women on thyroxine substitution are often dysregulated in early pregnancy
Hallengren Bengt, Lantz Mikael, Andreasson Bengt,
Department of Endocrinology, Malmö University Hospital, Malmö, Sweden Department of Pediatrics, Malmö University Hospital, Malmö, Sweden Department of Obstetrics and Gynecology, Malmö University Hospital, Malmö, Sweden
     
10.55 - 12.35   Oral Communication 2: Bone & Calcium Metabolism
Brown Hall
 Chairs: J. M. Kaufman (Belgium) & P. Lakatos (Hungary)
OC2.1 Effect of Once-Yearly Infusion of Zoledronic Acid 5 mg in Postmenopausal Women with Osteoporosis
Eastell Richard, Lakatos Peter, Black Dennis, Boonen Steven, Cosman Felicia, Cumings Steven, Delmas Pierre, Eriksen Erik Fink, Leung Ping Chung, Man Zulema, Mesenbrink Peter, Reid Ian, Cauley Jane
University of Sheffield, Sheffield, United Kingdom Semmelweis University, Budapest, Hungary University of California, San Francisco, San Francisco, CA, United States Leuven University Center for Metabolic Bone Diseases, Leuven, Belgium
OC2.2 Role of IGF System on the Regulation of Osteoblast Aromatase Activity In Vitro
Palermo Claudia, Arvigo Marica, Minuto Francesco
Department of Endocrinological & Metabolic Sciences and Center of Excellence for Biomedical Research, University of Genoa;, Genoa, Italy
OC2.3 Clinical and biochemical differences in patients affected with sporadic and type 1 multiple endocrine neoplasia (MEN) related primary hyperparathyroidism.
Eller-Vainicher Cristina, Massironi Sara, Peracchi Maddalena, Persani Luca, Beck-Peccoz Paolo, Spada Anna, Corbetta Sabrina
Endocrine Unit, Medical Sciences Department, University of Milan, Fondazione Ospedale Maggiore, Mangiagalli, Regina Elena IRCCS, Milan, Italy Gastroenterology Unit, Department of Medical Sciences, University of Milan, Fondazione Ospedale Maggiore, Mangiagalli, Regina Elena IRCCS, Milan, Italy Lab of experimental endocrinology, Department of Medical Sciences, University of Milan, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy Endocrinology and Diabetology Unit, Department of Medical-Surgical Sciences, University of Milan, Policlinico San Donato IRCCS, San Donato, Milan, Italy
OC2.4 Assessment of Prevalent Vertebral Deformities In Morphometric X-Ray Absorptiometry
Skowronska-Jozwiak Elzbieta, Pludowski Pawel, Karczmarewicz Elzbieta, Lewinski Andrzej, Lorenc Roman
Department of Endocrinology & Metabolic Diseases, The Medical University of Lodz, Lodz, Poland Department of Biochemistry and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland
OC2.5 Effect of gonadal status on baseline and after rhGH treatment prevalence of spinal deformities in adult patients with growth hormone deficiency (GHD)
Mazziotti Gherardo, Bianchi Antonio, Bonadonna Stefania, Nuzzo Monica, Cimino Vincenzo, Fusco Alessandra, De Marinis Laura, Giustina Andrea
Department of Internal Medicine, University of Brescia, Brescia, Italy Department of Endocrinology, Catholic University, Rome, Italy., Rome, Italy
OC2.6 Sunlight exposure and vitamin D supplementation at the institutionalized elderly – effects on calcium and bone metabolism
Bottermann Peter, Branisteanu Dumitru, Mogos Voichita, Zbranca Eusebie
University of Medicine and Pharmacy "Gr.T.Popa", Iasi, Romania Technical University, Munchen, Germany
OC2.7 Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells
Horie-Inoue Kuniko, Ichikawa Tomoe, Inoue Satoshi
 Research Center for Genomic Medicine, Saitama Medical University, Hidaka-shi, Saitama, Japan Graduate School of Medicine, the University of Tokyo, Bunkyo-ku, Tokyo, Japan
     
12.35 - 14.00   Novartis Satellite Symposium – Acromegaly – basic science and not clinical research will determine the future: a debate
Orange Hall
Chair: M. Sheppard (United Kingdom)
     
14.00 - 15.00   Poster session & Lunch
Comparative Endocrinology P1 - P7
Cytokines and Growth Factors P8 - P23
Diabetes & Cardiovascular P24 - P59
Endocrine Tumors & Neoplasia P97 - P138
Growrh & Development P180 - P189
Obesity & Metabolism P190 - P228
Signal Transduction P269 - P274
Steroid Receptors P275 - P285
Thyroid P286 - P339
     
14.30 - 15.30   Meet the Expert 01 - Clinical: Graves' Ophthalmopathy
Plenary Hall
ME1 Choosing and timing treatment options in Graves' Orbitopathy (GO)
W. van den Bosch (The Netherlands)
ME1 Endocrine Orbitopathy
Cs. Balázs (Hungary)
     
14.30 - 15.30   Meet the Expert 02 - Clinical: Mineralocoticoid Hypertension
Yellow Hall
ME2 Mineralocorticoid Hypertension
M. Mannelli (Italy)
     
14.30 - 15.30   Meet the Expert 03 - Basic to Clinical: Fetal programming by andorgen excess
Green Hall
ME3 Meet the Expert 03 - Fetal programming by androgen excess
A. Tsatsoulis (Greece)
     
14.30 - 15.30   Meet the Expert 04 - Clinical: Intensive insulin treatment in ICU
Blue Hall
ME4 Intensive insulin treatment in ICU
T. Pieber (Austria)
     
14.30 - 15.30   Meet the Expert 09 - Clinical: Turner Syndrome
Brown Hall
ME9 Turner Syndrome
E. Malecka-Tendera (Poland)
     
14.30 - 15.30   Meet the Expert 10 - Clinical: Indications, management and follow-up of bariatric surgery patients
Room III
ME10 Indications, management and follow up of bariatric surgery
B. Burguera (Spain) & M. Fried (Czech Republic)
     
14.30 - 15.30   Meet the Expert 11 - Basic to Clinical: Thyroid echocolordoppler
Orange Hall
ME11 Thyroid echocolordoppler
P. Vitti (Italy)
     
14.30 - 15.30   Meet the Expert 12 - Clinical: Stem cell therapy in endocrinology: reality and challenges
Room II
ME12 Stem Cell Therapy in Endocrinology: Reality and Challenges
M. Kassem (Denmark)
     
15.30 - 16.00   Tea Break & Exhibition
     
16.00 - 17.45   Symposium 6 - Basic to Clinical: Diabetes and Insulin
Plenary Hall
 Chairs: S. Del Prato (Italy) & V. Pirags (Latvia)
16:00 S6.1 Perspectives of islet cells transplantations
B. Keymeulen (Belgium)
16:25 S6.2 Cytokines as pathogenetic effectors in type 1 and type 2 diabetes
T. Mandrup-Poulsen (Denmark)
16.50 S6.3 GLP-1 as a drug target
T. Vilsbøll (Denmark)
17:15 S6.4 Engineering beta cells to recover insulin function
B. Soria (Spain)
     
16.00 - 17.45   Symposium 7 - Basic: Thyroid Cell Biology
Yellow Hall
 Chairs: C. Alvarez (Spain) & M. Nilsson (Sweden)
16:00 S7.1 New insights from zebrafish: The molecular and cellular base of thyroid development
K. Rohr (Germany)
16:25 S7.2 Involvement of cardiovascular development and non-cell autonomous signaling in mouse thyroid organogenesis
H. Fagman (Sweden)
16:50 S7.3 Thyroglobulin deposition and cathepsin-dependent Tg mobilization
K. Brix (Germany)
17:15 S7.4 Role of the complex Megalin-RAP in thyroglobulin trafficking
M. Marino (Italy)
     
16.00 - 17.45   Oral Communication 3: Endocrine Tumors & Neoplasia
Green Hall
 Chairs: B. Jarzab (Poland) & E. Malecka-Tendera (Poland)
OC3.1 Multiple somatostatin receptor subtypes activation reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion
Zatelli Maria Chiara, Piccin Daniela, Tagliati Federico, Ambrosio Maria Rosaria, Bianchi Antonio, Bondanelli Marta, Schmid Herbert A, Scanarini Massimo, De Marinis Laura, Maira Giulio, degli Uberti Ettore C
Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies - University of Ferrara , Ferrara, Italy Institute of Endocrinology, Catholic University of Rome, Rome, Italy Novartis Institutes for Biomedical Research, Oncology, Basel, Switzerland Division of Neurosurgery - Hospital of Padova, Padova, Italy
OC3.2 Adrenal lessions in multiple endocrine neoplasia type 1: data from the French group for the study of endocrine tumors (GTE)
Gatta Blandine, Monsaingeon Maud, Goudet Pierre, Murat Arnaud, Niccoli-Sire Patricia, Calender Alain, Rohmer Vincent, Chabre Olivier, Tabarin Antoine
Dpt Endocrinology, Bordeaux, France Dpt Surgery, Dijon, France Dpt Endocrinology, Nantes, France Dpt Endocrinology, Grenoble, France
OC3.3 BMP dependent effects on adrenal tumorigenesis and function
Johnsen Inga, Kaufmann Sarah, Spady Lilia, Beuschlein Felix
Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Medical Clinic, University Hospital Innenstadt, Ludwig Maximilians University, Munich, Germany
OC3.4 RET mutation - Tyr791Phe - the genetic cause of different diseases derived from neural crest
Vaclavikova Eliska, Dvorakova Sarka, Vlcek Petr, Skaba Richard, Bilek Radovan, Bendlova Bela
Dept. of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic Dept. of Nuclear Medicine and Endocrinology, 2nd Faculty of Medicine, Charles University and Hospital Motol, Prague, Czech Republic Dept. of Pediatric Surgery, 2nd Faculty of Medicine, Charles University and Hospital Motol, Prague, Czech Republic
OC3.5 [123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience
Hahner Stefanie, Stuermer Andrea, Fassnacht Martin, Kreissl Michael, Reiners Christoph, Beuschlein Felix, Zink Martina, Zolle Ilse, Schirbel Andreas, Allolio Bruno
University of Wuerzburg, Dept. of Endocrinology and Diabetology, Wuerzburg, Germany University of Wuerzburg, Dept. of Nuclear Medicine, Wuerzburg, Germany University of Munich, LMU, Division of Endocrine Research, Munich, Germany University of Vienna, Ludwig-Boltzmann-Institute of Nuclear Medicine, Vienna, Austria
OC3.6 ERß-Specific Transcriptional Profile in Colon Cancer
Martineti Valentina, Mascherini Massimiliano, Mavilia Carmelo, Carbonell Sala Silvia, Tognarini Isabella, Azzari Chiara, Stefanini Federico Mattia, Tonelli Francesco, Brandi Maria Luisa
Department of Internal Medicine, School of Medicine, University of Florence, Florence, Italy Department of Clinical Physiopathology, School of Medicine, University of Florence, Florence, Italy Department of Pediatrics, School of Medicine, University of Florence, Florence, Italy Department of Statistics, University of Florence, Florence, Italy
OC3.7 Fasting Insulin Levels are Predictors of Colonic Lesions in Patients with Acromegaly: an Observational, Open, Prospective Study in 189 Patients
Colao Annamaria, Pivonello Rosario, Galdiero Mariano, Auriemma Renata S., Ferone Diego, Marzullo Paolo, Lombardi Gaetano
Department of Molecular and Clinical Endocrinology and Oncology, section of Endocrinology, University “Federico II” of Naples, Naples, Italy Department of Endocrine and Metabolic Diseases, University of Genova, Genova, Italy Section of Endocrinology, Auxologic Institute of Verbania, Verbania, Italy
     
16.00 - 17.45   Oral Communication 4: Neuroendocrinology Basic
Brown Hall
 Chairs: J. P. Castaño (Spain) & M. Malagon (Spain)
OC4.1 Organismal, cellular and molecular evolution of water balance regulation in vertebrates : the amphibian hinge
Acher Roger, Chauvet Jacqueline, Rouillé Yves
University Paris VI, Paris, France
OC4.2 Growth Hormone-Releasing Hormone (GHRH) exerts protective effects on adult rat hippocampal progenitor cells.
Destefanis Silvia, Johansson Inger, Aberg David, Granata Riccarda, Ghigo Ezio, Isgaard Jorgen
University of Turin, Turin, Italy Sahlgrenska University, Goteborg, Sweden
OC4.3 Absence of germline AIP mutations in early onset sporadic somatotropinomas
Gomes Leonor, Prazeres Hugo, Paiva Isabel, Ribeiro Cristina, Rebelo Olinda, Martins Teresa, Lacerda Manuela, Carvalheiro Manuela
Serviço de Endocrinologia, Diabetes e Metabolismo dos Hospitais da Universidade de Coimbra, Coimbra, Portugal Laboratório de Patologia Molecular do Serviço de Anatomia Patológica do Centro Regional de Oncologia de Coimbra do Instituto Português de Oncologia, EPE, Coimbra, Portugal Serviço de Anatomia Patológica dos Hospitais da Universidade de Coimbra, Coimbra, Portugal
OC4.4 Is there a role for dopamine d2 receptor gene polymorphisms in determining cabergoline sensitivity in prolactin-secreting pituitary adenomas?
Filopanti Marcello, Barbieri Anna Maria, Angioni Rita, Lania Andrea, Mantovani Giovanna, Spada Anna, Beck-Peccoz Paolo
Endocrine Unit, Dept. Medical Sciences, University of Milan; Fondazione Ospedale Maggiore Policlinico IRCCS, Milano, Italy
OC4.5 Lack of nuclear Hes1 expression coincides with transformation of endocrine pancreatic cells in Men1 knock out mice
Johansson Térèse, Halin Lejonklou Margareta, Skogseid Britt
Institution of Medical Sciences, Uppsala, Sweden
OC4.6 Metabolic Abnormalities in Patients with Adrenal Adenomas May Be Associated with BclI Polymorphism in the Glucocorticoid Receptor (GR) Gene and Expression of Tumor-Specific Hsp70 Isoforms
Damjanovic Svetozar, Antic Jadranka, Beleslin Bojana, Ognjanovic Sanja, Vignjevic Jovana, Petakov Milan, Macut Djuro, Paunovic Ivan, Isailovic Tatjana, Popovic Bojana, Bozic Ivana
Institute for endocrinology, diabetes and metabolic diseases, Belgrade, Serbia
OC4.7 Function and Evolution of GHRH, PACAP and PRP in Vertebrates
Chow Billy KC, Siu Francis KY, Tam Janice KV, Lee Leo TO
University of Hong Kong, Pokfulam, HK, SAR, China
     
17.45 - 18.30   Plenary Lecture 2
Plenary Hall
 Chairs: R. Bouillon (Belgium) & R. Gaillard (Switzerland)
PL2 Reciprocal regulations of bone and energy metabolisms
G. Karsenty (USA)
     
18.30 - 20.00   Pfizer Satellite Symposium - Medical Treatment of Acromegaly - current evidence and new insights
Orange Hall
 Chair: P. Trainer (United Kingdom)
     
20.00 -    Take it easy party
     

30/04/2007
08.00 - 08.45   Plenary Lecture 3
Plenary Hall
 Chairs: A. Pinchera (Italy) & M. Sheppard (United Kingdom)
PL3 Importance of transporters for cellular entry of thyroid hormone
T. J. Visser (The Netherlands)
     
08.45 - 10.25   Symposium 08 - Clinical: Advances in adrenal hypersecretory disorders
Yellow Hall
 Chairs: B. Allolio (Germany) & Z. Zheng-pei (China)
08:45 S8.1 Autocrine-paracrine pathways in primary adrenal disorders
H. Lefebvre (France)
09:10 S8.2 Carney Complex and Primary Pigmented Nodular Adrenocortical Disease
J. Bertherat (France)
09:35 S8.3 Diagnosis and prevalence of primary aldosteronism
G. P. Rossi (Italy)
10:00 S8.4 Adrenocortical carcinoma: current and future therapeutic options
M. Fassnacht (Germany)
     
08.45 - 10.25   Symposium 09 - Clinical: Imaging in endocrinology
Green Hall
 Chairs: P. Lind (Austria) & J. Marek (Czech Republic)
08:45 S9.1 PET in diagnostics of metabolic alterations and endocrinological tumours
P. Nuutila (Finland)
09:10 S9.2 Micro-, nano- and molecular imaging of bone
C. C. Gluer (Germany)
09:35 S9.3 New tracers for neuroendocrine tumors
M. P. M. Stokkel (The Netherlands)
10:00 S9.4 Echoendoscopy for the diagnosis of pancreatic endocrine tumors
C. De Angelis (Italy)
     
08.45 - 10.25   Symposium 10 - Basic: GH & prolactin at their targets
Orange Hall
 Chairs: F. Casanueva (Spain) & C. Strasburger (Germany)
08:45 S10.1 Cellular control mechanisms for GH sensitivity
G. J. Strous (The Netherlands)
09:10 S10.2 GH receptor signalling
G. Norstedt (Sweden)
09:35 S10.3 Gene expression profiling of the antiangiogenic factor 16K human Prolactin (hPRL) on endothelial cells underlines the key role of NF-kB and reveals novel mechanisms of action
J. Martial (Belgium)
10:00 S10.4 Development of human prolactin receptor antagonists
V. Goffin (France)
     
10.25 - 10.55   Coffee Break & Exhibition
     
10.55 - 12:35   Symposium 11 - Basic to Clinical: Polycystic ovary syndrome
Plenary Hall
 Chairs: F. Kelestimur (Turkey) & D. Micic (Serbia)
10:55 S11.1 The CAG Repeat Polymorphism of the Androgen Receptor Gene is an independent Risk Factor for Polycystic Ovary Syndrome (PCOS)
A. Schuering (Germany)
11:20 S11.2 Genetic Markers of Polycystic Ovary Syndrome (PCOS)
J. Laven (The Netherlands)
11:45 S11.3 Hyperandrogenism and Metabolic Syndrome (MBS) in Polycystic Ovary Syndrome (PCOS)
A. Dunaif (USA)
12:10 S11.4 Individual pharmacological therapy for polycystic ovary syndrome: lessons from the phenotype
R. Pasquali (Italy)
     
10.55 - 12.35   Symposium 12 - Basic: Hypothalamic network controlling food intake
Orange Hall
 Chairs: U. Pagotto (Italy) & M. Palkovits (Hungary)
10:55 S12.1 Processing of metabolic signals in the hypothalamus: the integrative role of the paraventricular nucleus
Z. Liposits (Hungary)
11:20 S12.2 Neurotransmitter content of orexigenic and anorexigenic neurones
B. Meister (Sweden)
11:45 S12.3 The picture of the hypothalamus is becoming clearer: new concept of cross-talk
T. Horvath (USA)
12:10 S12.4 Whom is insulin in the brain speaking to?
J. Bruening (Germany)
     
10.55 - 12.35   Oral Communication 5: Thyroid Basic
Green Hall
 Chairs: M. Alevizaki (Greece) & W. Wiersinga (The Netherlands)
OC5.1 Structure-function of glycoprotein hormones using site-directed mutagenesis and gene transfer: Designing new agonists and antagonists
Fares Fuad, Azam Naiel, Bar-Shalom Rinat, Kraiem Zaki
Carmel medical Center and the Faculty of Medicine, Technion-israel Institute of Trechnology, Haifa, Israel
OC5.2 Tyroglobulin (Tg) depletion in receptor associated protein (RAP) KO mice is due to a reduction of Tg aggregates
Lisi Simonetta, Botta Roberta, Pinchera Aldo, Marcocci Claudio, Marinò Michele
Department of Endocrinology, University of Pisa, Pisa, Italy
OC5.3 Polarized plasma membrane targeting of the Na+/I- symporter (NIS) is regulated by its carboxy terminus
Dohan Orsolya, Portulano Carla, Ginter Chris, Carrasco Nancy
Albert Einstein College of Medicine, Bronx, New York, United States Institute of Experimental Medicine Hungarian Academy of Sciences and Szent Rokus Hospital and Institutions, Budapest, Hungary
OC5.4 BRAFV600E mutations but not RET/PTC rearrangements are correlated with a lower expression of NIS mRNA expression in papillary thyroid cancer (PTC)
Romei Cristina, Piampiani Pamela, Faviana Pinuccia, Basolo Fulvio, Bottici Valeria, Sculli Mariangela, Berti Piero, Materazzi Gabriele, Pinchera Aldo, Elisei Rossella
Department of Endocrinology, University of Pisa, Pisa, Italy Department of Surgery, University of Pisa, Pisa, Italy Department of Oncology, University of Pisa, Pisa, Italy
OC5.5 Transcriptional Regulation of Human Type 2 Deiodinase and Chorionic Gonadotropin Genes in Human Placenta: Emerging Evidence of a Common Promoter Code
Canettieri Gianluca, Santaguida Maria Giulia, Franchi Antonella, Della Guardia Michele, Gulino Alberto,
Centanni Marco University of Rome “La Sapienza”- Polo Pontino, Latina, Italy
OC5.6 A Crucial Role of Interleukin- 6 in the Pathogenesis of Thyrotoxicosis-related Disturbances of Bone Turnover in Mice
Mysliwiec Janusz, Zbucki Robert, Winnicka Maria Malgorzata, Sawicki Boguslaw, Nikolajuk Agnieszka, Kaminski Karol, Musial Wlodzimierz, Mysliwiec Piotr, Bondyra Zofia, Walecki Jerzy, Gorska Maria
Dept. of Endocrinology, Diabetology and Internal Diseases, Bialystok, Poland Dept. of General and Experimental Pathology, Bialystok, Poland Dept. of Histology and Embryology, Bialystok, Poland Dept. of Cardiology, Bialystok, Poland
OC5.7 The 1188A/C polymorphism of IL-12 gene in Graves’ disease.
Wawrusiewicz-Kurylonek Natalia, Gorska Maria, Mysliwiec Janusz, Kretowski Adam Jacek
Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland
     
10.55 - 12.35   Oral Communication 6: Cardiovascular Endocrinology
Brown Hall
 Chairs: F. Mantero (Italy) & T. Olsson (Sweden)
OC6.1 Growth hormone-releasing hormone prevents cardiomyocyte apoptosis and activates pi3k/akt, erk1/2 and creb signaling pathways
Granata Riccarda, Trovato Letizia, Destefanis Silvia, Settanni Fabio, Annunziata Marta, Gallo Davide, Ghigo Ezio
Dept. Internal Medicine, Div. Endcocrinology and Metabolism, University of Turin, Turin, Italy
OC6.2 Testosterone replacement therapy attenuates fatty streak formation and improves the high-density lipoprotein cholesterol profile in the Tfm mouse: an effect which is independent of the classical androgen receptor
Nettleship Joanne E, Jones Richard D, Channer Kevin S, Jones H. T
Hormone and Vascular Biology Group, Academic Unit of Diabetes, Endocrinology & Metabolism, Division of Genomic Medicine, University of Sheffield Medical School, Beech Hill Road , Sheffield, S10 2RX, United Kingdom Department of Cardiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Trust, Glossop Road, Sheffield, S10 2JF, United Kingdom
OC6.3 Plasma brain natriuretic peptide (BNP) levels predict acute right ventricular dysfunction in pulmonary embolism – prospective study on 70 patients
Pascu Alina Mihaela, Radoi Mariana, Coculescu Mihail
"Transilvania" University, Faculty of Medicine, Department of Pathophysiology, Cardiology Clinic, Brasov, Romania "Transilvania" University, Faculty of Medicine, Department of Internal Medicine, Cardiology Clinic, Brasov, Romania "Carol Davila" University of Medicine and Pharmacy, Department of Endocrinology, "C.I. Parhon" Institute of Endocrinology, Bucuresti, Romania
OC6.4 Carotid IMT and stiffness, aortic stiffness and pulse pressure: association with hormone therapy in postmenopausal women: baseline findings from the CASHMERE trial
Simon T., Boutouyrie P., Christin-Maitre S., Gompel A., Joanides R., Kearny-Schwartz A., Kuntz Ch., Laurent S., Pannier B., Pornel B., H. Struijker-Boudier H., Thuilliez Ch., Van Bortel L., Zannad F., Pithois-Merli I., Jaillon P.
Saint Antoine-UPMC ParisVI university-Hospital, paris, France HEGP-Paris V-University Hospital, paris, France Hotel Dieu-Paris V-University Hospital, paris, France CHU Rouen, Rouen, France
OC6.5 Effects of ezetimibe and/or simvastatin on